Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cell-free DNA Methylation for the Diagnosis and Monitoring of Endometrial Cancer: The Training and Validation Sets in China

NCT04651738 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04651738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cell-free DNA Methylation for the Diagnosis and Monitoring of Endometrial Cancer: The Training and Validation Sets in China
Lead sponsor
Lei Li
Phase
Not applicable
Overall status
Unknown status
Start date
December 18, 2020
Completion date
January 1, 2023
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cytology, diagnostic accuracy, dna methylation, endometrial cancer, liquid biopsy, training set, validation set